Anti-LGI4 Antibody Picoband®

LGI4 antibody

Boster Bio Anti-LGI4 Antibody Picoband® catalog # A12305-1. Tested in ELISA, IF, IHC, ICC, WB, Flow Cytometry applications. This antibody reacts with Human, Mouse, Rat. The brand Picoband indicates this is a premium antibody that guarantees superior quality, high affinity, and strong signals with minimal background in Western blot applications. Only our best-performing antibodies are designated as Picoband, ensuring unmatched performance.

Product Info Summary

SKU: A12305-1
Size: 100 µg/vial
Reactive Species: Human, Mouse, Rat
Host: Rabbit
Application: ELISA, Flow Cytometry, IF, IHC, ICC, WB

Customers Who Bought This Also Bought

Product Name

Anti-LGI4 Antibody Picoband®

View all LGI4 Antibodies

SKU/Catalog Number

A12305-1

Size

100 µg/vial

Form

Lyophilized

Description

Boster Bio Anti-LGI4 Antibody Picoband® catalog # A12305-1. Tested in ELISA, IF, IHC, ICC, WB, Flow Cytometry applications. This antibody reacts with Human, Mouse, Rat. The brand Picoband indicates this is a premium antibody that guarantees superior quality, high affinity, and strong signals with minimal background in Western blot applications. Only our best-performing antibodies are designated as Picoband, ensuring unmatched performance.

Storage & Handling

At -20°C for one year from date of receipt. After reconstitution, at 4°C for one month. It can also be aliquotted and stored frozen at -20°C for six months. Avoid repeated freezing and thawing.

Cite This Product

Anti-LGI4 Antibody Picoband® (Boster Biological Technology, Pleasanton CA, USA, Catalog # A12305-1)

Host

Rabbit

Contents

Each vial contains 4 mg Trehalose, 0.9 mg NaCl, 0.2 mg Na2HPO4.

Clonality

Polyclonal

Isotype

IgG

Immunogen

E.coli-derived human LGI4 recombinant protein (Position: E225-H531).

Cross-reactivity

No cross reactivity with other proteins.

Reactive Species

A12305-1 is reactive to LGI4 in Human, Mouse, Rat

Observed Molecular Weight

59 kDa

Calculated molecular weight

59.1 kDa

Background of LGI4

The leucine-rich, glioma inactivated gene 4 (LGI4) is a member of the LGI family. The LGI family consists of four of highly related proteins containing leucine-rich repeats (LRRs). Despite its high homology with LGI1 and similar pattern of expression, mutations in LGI4 have not been found to be associated with autodominant lateral temporal epilepsy (ADTLE). However, the LGI4 gene is located in a region linked to benign familial infantile convulsions and a GC-to-AT polymorphism in LGI4 was correlated with childhood absence epilepsy. Other studies showed that decreasing LGI4 expression in cultured cells inhibits myelination, indicating that LGI4 may play a role in neural development.

Antibody Validation

Boster validates all antibodies on WB, IHC, ICC, Immunofluorescence, and ELISA with known positive control and negative samples to ensure specificity and high affinity, including thorough antibody incubations.

View more details

Applications

A12305-1 is guaranteed for ELISA, Flow Cytometry, IF, IHC, ICC, WB Boster Guarantee

Assay Dilutions Recommendation

The recommendations below provide a starting point for assay optimization. The actual working concentration varies and should be decided by the user.

Western blot, 0.25-0.5 μg/ml, Human, Mouse, Rat
Immunohistochemistry(Paraffin-embedded Section), 2-5 μg/ml, Human
Immunocytochemistry/Immunofluorescence, 5 μg/ml, Human
Flow Cytometry (Fixed), 1-3 μg/1x106 cells, Human
ELISA, 0.1-0.5 μg/ml, -

Positive Control

WB: human HepG2 whole cell, human Hacat whole cell, human SiHa whole cell, human U251 whole cell, rat brain tissue, rat stomach tissue, mouse brain tissue, mouse stomach tissue
IHC: human bladder urothelial carcinoma tissue, human colorectal adenocarcinoma tissue, human glioma tissue, human liver cancer tissue, human lung cancer tissue
ICC/IF: SiHa cell
FCM: JK cell

Validation Images & Assay Conditions

Loading publications

No publications found

Do you have publications using this product? Share with us and receive a reward. Contact us for more information.

Publications not available. Please try again later.

Product has been cited in publications

No results found matching your query

  • Published: --- Journal: --- Application: --- Impact Factor: --- Species: --- PMID: --- View Article

Have you used Anti-LGI4 Antibody Picoband®?

Share your experimental results or join a short interview to earn up to $1,000 in product credits or other rewards.

0 Reviews For Anti-LGI4 Antibody Picoband®

Have a question?

Find answers in Q&As, reviews.

Can't find your answer?

Submit your question

0 Customer Q&As for Anti-LGI4 Antibody Picoband®

Order DetailsPrice
A12305-1

100μg

$370
A12305-1-Fluoro488

100 μg Fluoro488 conjugated (liquid)

$570
A12305-1-Fluoro550

100 μg Fluoro550 conjugated (liquid)

$570
A12305-1-Fluoro594

100 μg Fluoro594 conjugated (liquid)

$570
A12305-1-Fluoro647

100 μg Fluoro647 conjugated (liquid)

$670
A12305-1-APC

100 μg APC conjugated (liquid)

$820
A12305-1-FITC

100 μg FITC conjugated (liquid)

$570
A12305-1-Cy3

100 μg Cy3 conjugated (liquid)

$570
A12305-1-Biotin

100 μg Biotin conjugated (liquid)

$570
A12305-1-HRP

100 μg HRP conjugated (liquid)

$570
A12305-1-PE

100 μg PE conjugated (liquid)

$820
A12305-1-carrier-free

Carrier Free

$370
Rainbow Button View conjugates

Free Secondary Antibody

FREE  $95.00
FREE  $95.00
$40.00  $80.00
$65.00  $130.00
$67.50  $135.00
$75.00  $150.00
$30.00  $60.00
$75.00  $150.00
$55.00  $110.00
Choose an option to show lead time.
Get A Quote
In stock
Order Product
A12305-1
Buy one primary antibody get one 0.5ml HRP or Biotin secondary antibody for free.
*Sample sizes are prepared on demand and will take extra lead time. (cannot be conjugated)
$370.00

Troubleshooting

troubleshooting-box-image

Download troubleshooting handbooks for IHC, Western blot and ELISA for FREE.

Download Free PDFs Now

Boster Guarantee

Guaranteed product quality

Guaranteed product quality

We promise all of our products perform as described in datasheets.

This product is for Research Use Only. Not for use in diagnostic procedures.

Update date: May 1, 2026